Anti Hepatitis B surface Antibodies (Anti-HBs Titre)
New
770.00₹
In stock
All over India
0 Reviews
### **Anti-Hepatitis B Surface Antibodies (Anti-HBs) Test**
The **Anti-HBs (HBsAb) Titre test** is a quantitative blood assay that measures the concentration of protective antibodies against the Hepatitis B surface antigen.
* **Immunity Assessment:** It is primarily used to confirm immunity to the Hepatitis B virus (HBV), acquired either through successful vaccination or recovery from a past, resolved infection.
* **Clinical Threshold:** A titre level of **\ge 10 mIU/mL** is globally recognized as the threshold indicating active, long-term protective immunity against HBV.
* **Pre-employment & Monitoring:** This test is essential for healthcare workers, newborns of HBV-positive mothers, and immunocompromised patients to evaluate their defense status and determine the necessity of vaccine booster doses.
The **Anti-HBs (HBsAb) Titre test** is a quantitative blood assay that measures the concentration of protective antibodies against the Hepatitis B surface antigen.
* **Immunity Assessment:** It is primarily used to confirm immunity to the Hepatitis B virus (HBV), acquired either through successful vaccination or recovery from a past, resolved infection.
* **Clinical Threshold:** A titre level of **\ge 10 mIU/mL** is globally recognized as the threshold indicating active, long-term protective immunity against HBV.
* **Pre-employment & Monitoring:** This test is essential for healthcare workers, newborns of HBV-positive mothers, and immunocompromised patients to evaluate their defense status and determine the necessity of vaccine booster doses.
### **Anti-Hepatitis B Surface Antibodies (Anti-HBs) Test**
The **Anti-HBs (HBsAb) Titre test** is a quantitative blood assay that measures the concentration of protective antibodies against the Hepatitis B surface antigen.
* **Immunity Assessment:** It is primarily used to confirm immunity to the Hepatitis B virus (HBV), acquired either through successful vaccination or recovery from a past, resolved infection.
* **Clinical Threshold:** A titre level of **\ge 10 mIU/mL** is globally recognized as the threshold indicating active, long-term protective immunity against HBV.
* **Pre-employment & Monitoring:** This test is essential for healthcare workers, newborns of HBV-positive mothers, and immunocompromised patients to evaluate their defense status and determine the necessity of vaccine booster doses.
